Skip survey header

Foundation Frontiers Registration

Have you implemented circulating tumor DNA (ctDNA) monitoring in your practice? Join us to learn about how ctDNA-based treatment response monitoring (TRM) can provide objective insights into a patient’s response – potentially earlier than traditional methods like imaging. Expert speakers will share information and perspectives about the role of TRM, as well as emerging data. Foundation Medicine speakers will share insights from our personalized tissue-informed ctDNA monitoring test now available in the United States, FoundationOne®Tracker. This 30-minute session includes discussion and Q&A. 
 
1. Your Info
This question requires a valid email address.
2. Please register for one or more of the following dates:
Questions? Contact us at medicalaffairs@foundationmedicine.com

© 2023 Foundation Medicine, Inc. | Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc. www.foundationmedicine.com | Tel 888.988.3639 | Fax 617.418.2290 | US-FTL-2300035